Browse by Audience
Skip to content
Papers of the Week
A combination pharmacotherapy of tapentadol and pregabalin to tackle centrally driven Osteoarthritis pain.
Abstract
Many Osteoarthritis (OA) patients report with clinical features to their pain that cannot be explained by purely peripheral mechanisms. Yet, the analgesic agents available that tackle centrally driven chronic pain often provide only partial pain relief, or have dose-limiting side effects. We explored a combination therapy of the centrally acting analgesic agents tapentadol and pregabalin, to investigate if they could be used in combination to provide superior analgesia.